Hematology
Feature
Biosimilars poised to save $54 billion over the next decade
But uncertainty points to savings ranging from $24 billion to $150 billion.
From the Journals
RBCs from previously pregnant women linked to increased mortality in men
By contrast, all-cause mortality was not higher in female transplant recipients who received transfusions from previously pregnant females.
News
FDA approves test to screen donated blood for Zika virus
The cobas Zika test is the first test approved for screening the blood supply.
From the Journals
Blood donation intervals of 8 weeks safe for most donors
Ferritin screening may guide intervals for donation.
Latest News
Many years on metformin linked to anemia risk
LISBON – Why cumulative metformin use is associated with an increased risk of anemia is unclear, and needs to be investigated further, according...
News
FDA approves first gene therapy – tisagenlecleucel for ALL
“New technologies such as gene and cell therapies hold out the potential to transform medicine and create an inflection point in our ability to...
News
L-glutamine to prevent sickle cell complications featured in FDA podcast
Hear the FDA’s DISCO account of the role of L-glutamine’s recent approval for the acute complications of sickle cell disease.
Conference Coverage
Folic acid fortification prevents millions of cases of anemia
A strong public health rationale for mandatory food fortification.
Conference Coverage
VIDEO: Triple therapy study and new recommendations provide guidance on CAPS
MADRID – New data confirm that triple therapy with anticoagulation, corticosteroids, and plasma exchange or intravenous immunoglobulins increases...
Conference Coverage
Idarucizumab reversed dabigatran completely and rapidly in study
One drug reversed the anticoagulant effect of another completely and rapidly.
Conference Coverage
Monthly fitusiran showed promise in small phase I hemophilia trial
Monthly drug means good news for hemophilia A and B patients.